Prot #BHV7000-304: A Phase 2/3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BHV-7000 as Adjunctive Therapy in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-Clo

Project: Research project

Project Details

StatusActive
Effective start/end date12/9/2412/9/27

Funding

  • PPD Investigator Services, LLC (Prot #BHV7000-304 // Prot #BHV7000-304)
  • Biohaven Pharmaceuticals, Inc. (Prot #BHV7000-304 // Prot #BHV7000-304)